- Home
- APM vs MGRX Comparison
APM vs MGRX Comparison
Compare APM & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APM | MGRX |
|---|---|---|
| Founded | 2010 | 2021 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.1M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | APM | MGRX |
|---|---|---|
| Price | $0.86 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 219.0K | ★ 463.9K |
| Earning Date | 03-31-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $456,021.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.65 | $0.27 |
| 52 Week High | $4.47 | $2.75 |
Technical Indicators
Market Signals| Indicator | APM | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.60 | 46.02 |
| Support Level | $0.74 | $0.32 |
| Resistance Level | $0.98 | $0.49 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 12.59 | 13.75 |
Price Performance
Historical ComparisonAbout APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Aptorum's project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA). Substantially all of the company's revenues are derived from within Hong Kong.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.